MT-1
Limited evidence — Early or sparse dataWhat it is
Melanotan 1 (afamelanotide-related), a melanocortin agonist for pigmentation; a related drug is approved for a rare condition.
Melanotan 1 (afamelanotide-related) is a more selective melanocortin agonist for pigmentation. A related but different drug is approved for a rare condition.
Research context
Studied in relation to:
- Pigmentation research
Points in its favour in the literature:
- More selective than MT-2
- Related approved drug exists (different product)
Caveats and unknowns:
- Research-grade is not the approved drug
- Pigmentation/mole monitoring needed
- Unlicensed for human use
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature.
Published clinical / research context (not instructions)Reported research ~500 mcg–1 mg daily during loading.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 10 mg vial + 5 mL → 2 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 10mg | MT1 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.